Novo Nordisk Selects BE&K Building Group

June 24, 2024

Major Expansion in Clayton, NC

Project to enhance Novo Nordisk’s manufacturing capabilities with more than 1.4 million square feet of new space

Clayton, NC—June 24, 2024—BE&K Building Group (BE&K), a leading design-build and construction management firm, is proud to announce its partnership with global healthcare leader Novo Nordisk. The collaboration involves BE&K managing a new multi-product facility adjacent to Novo Nordisk’s existing operations in Clayton, North Carolina.

BE&K has dedicated over two years of detailed preparation for this endeavor, providing estimates, schedules, and procurement strategies, and has begun construction. The ambitious project will involve the construction of ten or more buildings and multi-building combinations, providing more than 1.4 million square feet.

BE&K will directly perform a significant portion of the work as Construction Manager and will serve as the Agency Construction Manager for the remainder of the work, providing oversight for the development of the facility that will span approximately 56 acres. The final state-of-the-art facility will be instrumental in manufacturing Novo Nordisk’s innovative treatments for obesity and other chronic diseases. Construction will gradually be finalized between 2027 and 2029.

“Clayton was the first manufacturing site for Novo Nordisk in the US, and this new, large-scale investment here confirms the continued importance of our production facilities in North Carolina. We are proud to be one of the cornerstones of our company’s growth,” said Niels Laurbjerg Nielsen, Corporate Vice President, Novo Nordisk. “For decades, we’ve partnered to foster a well-trained, dedicated and diverse local workforce here. We are one team driven by one purpose: to deliver more for the millions of people living with chronic diseases – and we will achieve that with this facility.”

“We are honored to partner with Novo Nordisk on this transformative project,” said Frank Holley, CEO of BE&K. “Our team’s extensive preparation and dedication to excellence and our client’s success reflect our commitment to delivering world-class facilities that produce healthcare solutions benefiting the global population. This expansion will not only bolster Novo Nordisk’s manufacturing capabilities but will also contribute significantly to the local community and economy in North Carolina’s Triangle region. We look forward to a successful collaboration with Novo Nordisk and the positive impact this project will bring.”

With a legacy of over 55 years in the construction industry, BE&K Building Group has been a pivotal force in North Carolina’s Triangle region since 1982. The company maintains its corporate headquarters in nearby Morrisville, North Carolina.

About BE&K Building Group

BE&K Building Group is an integrated construction services company serving life sciences, industrial + manufacturing, aviation + aerospace, healthcare, and additional select commercial markets for over 55 years. The company offers a comprehensive range of services, including preconstruction, design-build, construction management, and program management, with offices in the Carolinas, Texas, and Illinois. To learn more, visit, Facebook, Instagram, X, and LinkedIn.

About Novo Nordisk

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. The company’s purpose is to drive change to defeat serious chronic diseases, built upon their heritage in diabetes. They do so by pioneering scientific breakthroughs, expanding access to their medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 66,000 people in 80 countries and markets its products in around 170 countries. For more information, visit, Facebook, Instagram, X, LinkedIn and YouTube.

For additional information, press only:

Rick Helms
Vice President, Marketing + Communications